Combination of Immunotherapy and Antiangiogenic Therapy in Cancer—a Rational Approach

Sukhmani K. Padda; Karen L. Reckamp

doi:10.1016/j.jtho.2020.11.007

Combination of Immunotherapy and Antiangiogenic Therapy in Cancer—a Rational Approach

Sukhmani K. Padda
, Karen L. Reckamp

Stanford University
Cedars-Sinai Medical Center

Research output: Contribution to journal › Editorial

15 Scopus citations

Original language	English
Pages (from-to)	178-182
Number of pages	5
Journal	Journal of Thoracic Oncology
Volume	16
Issue number	2
DOIs	https://doi.org/10.1016/j.jtho.2020.11.007
State	Published - Feb 2021
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Angiogenesis Inhibitors/therapeutic use
Antibodies, Monoclonal, Humanized
Carcinoma
Carcinoma, Non-Small-Cell Lung
Esophageal Neoplasms
Humans
Immunotherapy
Lung Neoplasms
Neoplasms/drug therapy
Ramucirumab

Access to Document

10.1016/j.jtho.2020.11.007

Cite this

@article{59991028ee9d4ab09229b595ed70e099,

title = "Combination of Immunotherapy and Antiangiogenic Therapy in Cancer—a Rational Approach",

keywords = "Angiogenesis Inhibitors/therapeutic use, Antibodies, Monoclonal, Humanized, Carcinoma, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Humans, Immunotherapy, Lung Neoplasms, Neoplasms/drug therapy, Ramucirumab",

author = "Padda, \{Sukhmani K.\} and Reckamp, \{Karen L.\}",

year = "2021",

month = feb,

doi = "10.1016/j.jtho.2020.11.007",

language = "English",

volume = "16",

pages = "178--182",

journal = "Journal of Thoracic Oncology",

issn = "1556-0864",

publisher = "Elsevier Inc.",

number = "2",

}

TY - JOUR

T1 - Combination of Immunotherapy and Antiangiogenic Therapy in Cancer—a Rational Approach

AU - Padda, Sukhmani K.

AU - Reckamp, Karen L.

PY - 2021/2

Y1 - 2021/2

KW - Angiogenesis Inhibitors/therapeutic use

KW - Antibodies, Monoclonal, Humanized

KW - Carcinoma

KW - Carcinoma, Non-Small-Cell Lung

KW - Esophageal Neoplasms

KW - Humans

KW - Immunotherapy

KW - Lung Neoplasms

KW - Neoplasms/drug therapy

KW - Ramucirumab

UR - https://www.scopus.com/pages/publications/85099653971

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=purepublist2023&SrcAuth=WosAPI&KeyUT=WOS:000632634700004&DestLinkType=FullRecord&DestApp=WOS

U2 - 10.1016/j.jtho.2020.11.007

DO - 10.1016/j.jtho.2020.11.007

M3 - Editorial

C2 - 33494922

SN - 1556-0864

VL - 16

SP - 178

EP - 182

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

IS - 2

ER -

Combination of Immunotherapy and Antiangiogenic Therapy in Cancer—a Rational Approach

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this